RT Journal Article
SR Electronic
T1 Trans-ancestry genome-wide association study identifies novel genetic mechanisms in rheumatoid arthritis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.01.21267132
DO 10.1101/2021.12.01.21267132
A1 Ishigaki, Kazuyoshi
A1 Sakaue, Saori
A1 Terao, Chikashi
A1 Luo, Yang
A1 Sonehara, Kyuto
A1 Yamaguchi, Kensuke
A1 Amariuta, Tiffany
A1 Too, Chun Lai
A1 Laufer, Vincent A
A1 Scott, Ian C
A1 Viatte, Sebastien
A1 Takahashi, Meiko
A1 Ohmura, Koichiro
A1 Murasawa, Akira
A1 Hashimoto, Motomu
A1 Ito, Hiromu
A1 Hammoudeh, Mohammed
A1 Al Emadi, Samar
A1 Masri, Basel K
A1 Halabi, Hussien
A1 Badsha, Humeria
A1 Uthman, Imad W
A1 Wu, Xin
A1 Lin, Li
A1 Lin, Ting
A1 Plant, Darren
A1 Barton, Anne
A1 Orozco, Gisela
A1 Verstappen, Suzanne MM
A1 Bowes, John
A1 MacGregor, Alexander J
A1 Honda, Suguru
A1 Koido, Masaru
A1 Tomizuka, Kohei
A1 Kamatani, Yoichiro
A1 Tanaka, Hiroaki
A1 Tanaka, Eiichi
A1 Suzuki, Akari
A1 Maeda, Yuichi
A1 Yamamoto, Kenichi
A1 Miyawaki, Satoru
A1 Xie, Gang
A1 Zhang, Jinyi
A1 Amos, Chris
A1 Keystone, Ed
A1 Wolbink, Gertjan
A1 van der Horst-Bruinsma, Irene
A1 Cui, Jing
A1 Liao, Katherine P
A1 Carroll, Robert J
A1 Lee, Hye-Soon
A1 Bang, So-Young
A1 Siminovitch, Katherine A
A1 de Vries, Niek
A1 Alfredsson, Lars
A1 Rantapää-Dahlqvist, Solbritt
A1 Karlson, Elizabeth W
A1 Bae, Sang-Cheol
A1 Kimberly, Robert P
A1 Edberg, Jeffrey C
A1 Mariette, Xavier
A1 Huizinga, Tom
A1 Dieudé, Philippe
A1 Schneider, Matthias
A1 Kerick, Martin
A1 Denny, Joshua C
A1 The Biobank Japan Project
A1 Matsuda, Koichi
A1 Matsuo, Keitaro
A1 Mimori, Tsuneyo
A1 Matsuda, Fumihiko
A1 Fujio, Keishi
A1 Tanaka, Yoshiya
A1 Kumanogoh, Atsushi
A1 Traylor, Matthew
A1 Lewis, Cathryn M
A1 Eyre, Stephen
A1 Xu, Huji
A1 Saxena, Richa
A1 Arayssi, Thurayya
A1 Kochi, Yuta
A1 Ikari, Katsunori
A1 Harigai, Masayoshi
A1 Gregersen, Peter K
A1 Yamamoto, Kazuhiko
A1 Bridges, S. Louis
A1 Padyukov, Leonid
A1 Martin, Javier
A1 Klareskog, Lars
A1 Okada, Yukinori
A1 Raychaudhuri, Soumya
YR 2021
UL http://medrxiv.org/content/early/2021/12/05/2021.12.01.21267132.abstract
AB Trans-ancestry genetic research promises to improve power to detect genetic signals, fine-mapping resolution, and performances of polygenic risk score (PRS). We here present a large-scale genome-wide association study (GWAS) of rheumatoid arthritis (RA) which includes 276,020 samples of five ancestral groups. We conducted a trans-ancestry meta-analysis and identified 124 loci (P < 5 × 10-8), of which 34 were novel. Candidate genes at the novel loci suggested essential roles of the immune system (e.g., TNIP2 and TNFRSF11A) and joint tissues (e.g., WISP1) in RA etiology. Trans-ancestry fine mapping identified putatively causal variants with biological insights (e.g., LEF1). Moreover, PRS based on trans-ancestry GWAS outperformed PRS based on single-ancestry GWAS and had comparable performance between European and East Asian populations. Our study provides multiple insights into the etiology of RA and improves genetic predictability of RA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe MyEIRA study was funded by grant from Ministry of Health Malaysia (NMRR-08-820-1975) and the Swedish National Research Council (DNR-348-2009-6468). The GENRA study and the CARDERA genetics cohort genotyping were funded by Versus Arthritis (Grant Reference 19739 to ICS). The Nurses Health Study (NHS cohort) is funded by the NIH (R01 AR049880, UM1 CA186107, R01 CA49449, U01 CA176726, and R01 CA67262). The Swedish EIRA study was supported by the Swedish Research Council (to LK, LP and LA).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All cohorts obtained informed consent from all participants by following the protocols approved by their institutional ethical committees. We have complied with all relevant ethical regulations. IRB of participating institutions (including Brigham And Women's Hospital, Osaka University, and Riken) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe summary statistics and the PRS model with the best performance are publicly available at the following link: https://data.cyverse.org/dav-anon/iplant/home/kazuyoshiishigaki/ra_gwas/ra_gwas-10-28-2021.tar. The codes are available at our website: https://github.com/immunogenomics/RA_GWAS. https://data.cyverse.org/dav-anon/iplant/home/kazuyoshiishigaki/ra_gwas/ra_gwas-10-28-2021.tar